AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

The Dark Enlightenment of AI has turned efficiency into ideology. Here’s how it’s reshaping brands, leadership, and the ...

B y any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Is artificial intelligence polluting the internet? A few months ago, I was lying in bed, lightly clutching my phone, when ...

A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...

Kempf is the chap who keeps VLC going and he blogged earlier this week that the Free Software Foundation Europe (FSFE) gave ...

Odyssey Math Tuition, a tuition agency in Singapore, has launched a dedicated JC 1 math tuition elearning course to support ...

Recursion announced Najat Khan, PhD, currently chief R&D and commercial officer and a board member, will succeed co-founder and CEO Chris Gibson, PhD as CEO and president. Khan will also continue in ...

A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company's ...